Complete Genomics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (26)

Latest Posts

About This Stock More About This Stock
ETF Battles: Finding The Top Genomics Biotech ETF – A Triple Header Of ARKG Vs IDNA Vs GNOM
Video By: Ron DeLegge
Thursday, October 21, 2021 4:00 PM EDT
The search for therapies tackling chronic illnesses like cancer, diabetes, and heart disease has put stocks in the biotechnology and genomics industry sector on center stage.
In this video: GNOM, ARKG, IDNA
Watch
A Comprehensive Guide To Genomic ETFs
Article By: Zacks Investment Research
Sunday, July 11, 2021 1:59 PM EDT
Given the growing applications of gene-editing, it is a rising market which offers endless opportunities. Growing demand for personalized medicine, solid investments and higher R&D activities will soon make genomics the next big thing in the space.
In this article: GNOM, PBE, ARKG, IDNA, NTLA, CRSP Also: BEAM, EDIT
Read
FV ETF Battles ARKG Vs. GNOM - What's The Better Genomic/Biotech Play?
Video By: Ron DeLegge
Friday, June 4, 2021 5:00 AM EDT
Each ETF is judged against the other in key categories like cost, exposure strategy, performance, and a mystery category.
In this video: GNOM, ARKG
Watch
4 Best ETF Sectors Of Q4
Article By: Zacks Investment Research
Sunday, December 27, 2020 2:21 AM EDT
Small caps beat the major indexes, but the sectors that did even better are clean energy, regional banking, cannabis, and biotech.
In this article: KBWR, GNOM, QCLN, KRE, TAN, ARKG, YOLO, CNBS, MSOS Also: QQQ, DIA, IWM, SPY
Read
ETFs In Focus On Bayer's Bet On Gene Therapy
Article By: Sweta Killa
Thursday, October 29, 2020 11:58 PM EDT
Merger and acquisition activities have heated up in recent months and the niche spaces are in the limelight. After the telemedicine industry, gene therapy stocks jumped on the bandwagon.
In this article: GNOM, PBE, ARKG, IDNA
Read

Latest Tweets for $GNOM

No tweets yet!

PARTNER HEADLINES